UCB and Microsoft Expand Collaboration to Accelerate Drug Discovery and Development

By PR Newswire9 days ago

BRUSSELS and ATLANTA, Feb. 23, 2021 /PRNewswire/ -- Through this collaboration with Microsoft, UCB seeks to discover and develop medicines faster for people living with severe diseases in immunology and neurology Microsoft will provide AI technology and applied scientists to work...

Continue read on prnewswire.com